Hanmi Pharm. Co., Ltd. (KRX:128940)
461,500
+39,500 (9.36%)
Nov 20, 2026, 12:50 PM KST
| Market Cap | 5.86T +0.2% |
| Revenue (ttm) | 1.56T +6.6% |
| Net Income | 138.15B +18.6% |
| EPS | 10,887.44 +18.5% |
| Shares Out | 12.69M |
| PE Ratio | 42.39 |
| Forward PE | 24.93 |
| Dividend | 2,000.00 (0.43%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 126,492 |
| Open | 412,500 |
| Previous Close | 422,000 |
| Day's Range | 412,500 - 467,500 |
| 52-Week Range | 302,000 - 647,000 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 636,363.64 (+37.89%) |
| Earnings Date | Oct 27, 2026 |